<DOC>
	<DOC>NCT01370187</DOC>
	<brief_summary>The aim of the current study is to evaluate the effect of Montelukast in treatment of acute bronchiolitis and postbronchiolitis viral induced wheezing of infants 3 to 12 months of age in Bandar Abbas Children' hospital.</brief_summary>
	<brief_title>Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing</brief_title>
	<detailed_description>All the patients will be evaluated at the baseline, during hospitalization (daily) and at 2 months and 6 months after starting the intervention.</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Respiratory Sounds</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>infant in 312 months of age with first episode of wheezing or bronchiolitis written informed consent by parents Previous wheezing episode or confirmed asthma or bronchiolitis recent bronchodilator use immune deficient immunosuppressive drug use croup or pneumonia diagnosis loss of follow up</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bronchiolitis</keyword>
	<keyword>Postbronchiolitis wheezing</keyword>
	<keyword>Montelukast</keyword>
</DOC>